— Thermo Fisher Scientific (NYSE: TMO) reported third-quarter 2019 earnings of $2.94 per share, vs. $2.87 per share expected.
— Revenues grew 6% to $6.27 billion, vs. $6.18 billion expected.
— Raised FY19 revenue guidance to $25.34 – $25.50 billion vs. prior guidance of $25.30 – $25.50 billion.
— Adjusted EPS guidance for FY19 raised to a new range of $12.28 – $12.34, vs. earlier guidance of $12.16 – $12.26.
— TMO shares have gained 28% since the beginning of this year.
Last month, the IPO market was in a full swing. IPOs of Snowflake (NYSE: SNOW) and JFROG (NASDAQ: FROG) had an impressive opening day in September, the former creating a
PepsiCo Inc. (NASDAQ: PEP) beat market expectations on both revenue and earnings for the third quarter of 2020. The company saw the momentum continue in its snacks business while the
With more and more people turning to virtual entertainment sources, amid the virus-related movement restrictions, video game publishers like Electronic Arts (NASDAQ: EA) are witnessing unusually high demand. Not surprisingly,